Home›Companies›Biotech & Pharma›Stemtrix

Stemtrix Corp.

Makes medicines for bacterial infections in people and animals.

Updated Nov 21, 2026·Latest SEC filing Feb 10, 2023·Suggest an edit

About Stemtrix

Stemtrix is a private company based in Dover, Delaware, incorporated in 2023 in Delaware. It has reported $0 raised in one offering on Form D since February 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetFeb 10, 2023$0of $20.0M target0—EquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Stemtrix's Form D filed Feb 10, 2023.

EK
Evgenii Koluga
President and director

Sources

  1. SECStemtrix Corp. filing history
  2. ResearchMIT Solve: Stemtrix Corp.